Insider activity at BiomX Inc. has been all selling for a year now: about $8.2 million from one seller, and zero buyers with their own money.
That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.
No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Yeganeh Reuven | Director | Sell | 450,000 | $5.00 | $2.2M | SEC |
| Mar 18, 2026 | Yeganeh Reuven | Director | Sell | 530,000 | $5.00 | $2.6M | SEC |
| Mar 13, 2026 | Yeganeh Reuven | Director | Sell | 370,000 | $5.00 | $1.9M | SEC |
| Mar 13, 2026 | Yeganeh Reuven | Director | Sell | 300,000 | $5.00 | $1.5M | SEC |
| May 20, 2024 | GORDON CARL L | 10% Owner | Sell | 24,344 | $0.38 | $9K | SEC |
| Dec 1, 2023 | Oron Assaf | Executive Officer | Sell | 5,444 | $0.40 | $2K | SEC |
| Dec 1, 2023 | Oron Assaf | Executive Officer | Sell | 3,414 | $0.35 | $1K | SEC |
| Dec 1, 2023 | Oron Assaf | Executive Officer | Sell | 2,056 | $0.34 | $699 | SEC |
| May 24, 2023 | Oron Assaf | Executive Officer | Buy | 3,192 | $0.27 | $862 | SEC |
| May 22, 2023 | Oron Assaf | Executive Officer | Buy | 6,521 | $0.28 | $2K | SEC |
| May 22, 2023 | Oron Assaf | Executive Officer | Buy | 1,201 | $0.27 | $324 | SEC |
| Mar 17, 2023 | OrbiMed Israel GP Ltd. | 10% Owner | Buy | 348,000 | $0.25 | $87K | SEC |
In the last 12 months BiomX Inc. insiders made open-market purchases worth about $0 and sales worth about $8.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PHGE was filed on 2026-03-18.
No congressional trades in PHGE were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).